官方服务：
资源简介：
Response to osimertinib treatment.
应用场景：
创建时间：
2019-08-23
相关数据集
DataSheet_5_Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment.xlsx
BackgroundTo evaluate the potential treatment for patients with non-small cell lung cancer (NSCLC) and rare malignant pulmonary lymphangitis carcinomatosis (PLC), our study provided a genomic profile
NIAID Data Ecosystem30
J-REGISTER: real-world study of Japanese patients with EGFR mutation-positive NSCLC treated with first-line afatinib
The J-REGISTER study assessed outcomes and subsequent treatment in patients with EGFR mutation-positive NSCLC treated with first-line afatinib, including patients with uncommon EGFR mutations. This r
NIAID Data Ecosystem20
Supplementary Table 3. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
Supplementary Table 3. Real world data on treatment outcomes in EGFR mutant NSCLC patients receiving osimertinib in second or further lines Cox regression univariate and multiv
NIAID Data Ecosystem10
Supplementary Table 2. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
Supplementary Table 2 . Real world data on treatment outcomes in EGFR mutant NSCLC patients receiving osimertinib in second or further lines Cox regression univariate and multivariate anal
DataCite Commons2024-05-16 更新20
Supplementary Material for: Tofacitinib for the management of coexisting pemphigoid nodularis and psoriasis: a case report and review of the literature
Pemphigoid Nodularis (PN) is identified as a rare clinical variant of bullous pemphigoid (BP), often requiring detailed diagnostic methods due to its atypical presentations, with the concurrent occurr
NIAID Data Ecosystem10
